D
David K. Blough
Researcher at University of Washington
Publications - 112
Citations - 10711
David K. Blough is an academic researcher from University of Washington. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 48, co-authored 112 publications receiving 9725 citations. Previous affiliations of David K. Blough include Duke University & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Complementary and Alternative Medicine Use, Patient-reported Outcomes, and Treatment Satisfaction Among Men With Localized Prostate Cancer
Scott D. Ramsey,Steven B Zeliadt,Steven B Zeliadt,David K. Blough,Catherine R. Fedorenko,Megan E. Fairweather,Cara L. McDermott,David F. Penson,Stephen K. Van Den Eeden,Ann S. Hamilton,Neeraj Arora +10 more
TL;DR: The Prostate CAncer Therapy Selection Study as mentioned in this paper evaluated the association between complementary and alternative medicine (CAM) use, satisfaction with treatment, and patient-reported outcomes after treatment.
Journal ArticleDOI
A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia.
Mindy M. Cheng,Bernardo H. L. Goulart,Bernardo H. L. Goulart,David L. Veenstra,David K. Blough,Emily Beth Devine +5 more
TL;DR: The results suggest that FCR has relatively higher potential of preventing disease progression in younger, healthier, treatment-naïve CLL patients and should be considered an optimal initial treatment strategy for this patient population.
Journal ArticleDOI
Outcomes predicted by phosphorous in chronic kidney disease: a retrospective CKD-inception cohort study
TL;DR: Investigating the relationship between CKD and serum phosphorous found that increased levels of phosphorous are related to excess rates of RRT, and motivates randomized controlled trials to investigate the clinical value of such interventions.
Journal ArticleDOI
Colony-Stimulating Factor Use and Impact on Febrile Neutropenia Among Patients with Newly Diagnosed Breast, Colorectal, or Non–Small Cell Lung Cancer Who Were Receiving Chemotherapy
Jeannine S. McCune,Sean D. Sullivan,David K. Blough,David K. Blough,Lauren Clarke,Cara L. McDermott,Jennifer Malin,Scott D. Ramsey,Scott D. Ramsey +8 more
TL;DR: To determine the impact of primary prophylactic colony‐stimulating factor (CSF) use on febrile neutropenia in a large patient population receiving contemporary chemotherapy regimens to treat breast cancer, colorectal cancer, or non–small cell lung cancer (NSCLC).
Journal ArticleDOI
Development of a quantifiable symptom assessment tool for patients with chronic bronchitis: the Chronic Bronchitis Symptoms Assessment Scale
David H. Au,David K. Blough,Leonard Kirchdoerfer,Kevin B. Weiss,Edmunds M. Udris,Sean D. Sullivan +5 more
TL;DR: The Chronic Bronchitis Symptoms Assessment Scale is an easy to administer, once daily or once weekly, valid and reliable outcome measure for assessing symptom severity among patients with chronic bronchitis.